Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study.

Abstract

OBJECTIVES There is evidence that androgens are breast protective and that testosterone therapy treats many symptoms of hormone deficiency in both pre and postmenopausal patients. However, unlike estrogen and progestins, there is a paucity of data regarding the incidence of breast cancer in women treated with testosterone therapy. This study was designed to… (More)
DOI: 10.1016/j.maturitas.2013.08.002

Topics

5 Figures and Tables

Cite this paper

@article{Glaser2013ReducedBC, title={Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study.}, author={Rebecca L. Glaser and Constantine Dimitrakakis}, journal={Maturitas}, year={2013}, volume={76 4}, pages={342-9} }